GLONGHUI, September 26丨Baiben Healthcare (02293.HK) announced that for the year ended June 30, 2023, the company's revenue was approximately HK$127 million, a year-on-year decrease of about 9.8%. Profit attributable to equity holders of the company was approximately HK$46.9 million, a year-on-year decrease of approximately 20.0%. The recommended final dividend is HK3.75 cents per common share (2022: HK5.00 cents per common share).
百本医护(02293.HK)年度纯利减少约20.0%至约4690万港元 末期息3.75港仙
The annual net profit of Bauben Healthcare (02293.HK) decreased by approximately 20.0% to approximately HK$46.9 million, with a final interest rate of 3.75 HK cents
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.